Reciprocal Control of Forkhead box O 3a and c-Myc via the Phosphatidylinositol 3-Kinase Pathway Coordinately Regulates p27Kip1 Levels

Journal of Immunology

Volumn 172, Issue 9, 2004, Pages 5522-5527

  Chandramohan, Vidyalakshmi ^a   Jeay, Sébastien ^a   Pianetti, Stefania ^a   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN P27; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOMA CELL; CELL GROWTH; CONTROLLED STUDY; DNA VECTOR; DOWN REGULATION; GENETIC TRANSCRIPTION; GROWTH DISORDER; LYMPHOMA CELL; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 2142662252     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.9.5522     Document Type: Article

References (37)

1. 1-phase progression. Genes Dev. 13:1501.
2. Ezhevsky, S. A., H. Toyoshima, T. Hunter, and D. W. Scott. 1996. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas. Mol. Biol. Cell 7:553.
3. Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 15:2991.
4. Katayose, Y., M. Kim, A. N. Rakkar, Z. Li, K. H. Cowan, and P. Seth. 1997. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57:5441.
5. Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J. Immunol. 163:6530.
6. Erlanson, M., and G. Landberg. 2001. Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas. Leuk. Lymphoma 40:461.
7. Chiarle, R., M. Pagano, and G. Inghirami. 2001. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res. 3:91.
8. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
9. Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272:7093.
10. Kip1 mRNA and protein in murine B cells. J. Immunol. 160:770.
11. Kip1 protein in cervical carcinoma. Gynecol. Oncol. 69:230.
12. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688.
13. kip1. Nature 404:782.
14. KIP1. Mol. Cell. Biol. 20:9138.
15. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857.
16. Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene 20:7352.
17. Schauer, S. L., Z. Wang, G. E. Sonenshein, and T. L. Rothstein. 1996. Maintenance of nuclear factor-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 157:81.
18. Arsura, M., M. Wu, and G. E. Sonenshein. 1996. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα. Immunity 5:31.
19. Pianetti, S., M. Arsura, R. Romieu-Mourez, R. J. Coffey, and G. E. Sonenshein. 2001. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20:1287.
20. Lee, H., M. Arsura, M. Wu, M. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1169.
21. Wu, M., M. Arsura, R. E. Bellas, M. J. FitzGerald, H. Lee, S. L. Schauer, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16:5015.
22. Maheswaran, S., I. E. McCormack, and G. E. Sonenshein. 1991. Changes in phosphorylation of myc oncogene and RB antioncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line. Oncogene 6:1965.
23. Adams, J. M., S. Gerondakis, E. Webb, L. M. Corcoran, and S. Cory. 1983. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 80:1982.
24. Arsura, M., and G. E. Sonenshein. 2001. The roles of the c-myc and c-myb oncogenes in hematopoiesis and leukemogenesis. In Transcription Factors: Normal and Malignant Development of Blood Cells. K. Ravid and J. D. Licht, eds. Wiley-Liss. New York, p. 521.
25. Okkenhaug, K., and B. Vanhaesebroeck. 2003. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3:317.
26. Carey, G. B., and D. W. Scott. 2001. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas. J. Immunol. 166:1618.
27. Arsura, M., F. Mercurio, A. L. Oliver, S. S. Thorgeirsson, and G. E. Sonenshein. 2000. Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol. Cell. Biol. 20:5381.
28. Suzuki, H., S. Matsuda, Y. Terauchi, M. Fujiwara, T. Ohteki, T. Asano, T. W. Behrens, T. Kouro, K. Takatsu, T. Kadowaki, et al. 2003. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4:280.
29. Ruuth, K., L. Carlsson, B. Hallberg, and E. Lundgren. 2001. Interferon-α promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 284:583.
30. Gilmore, T., M. E. Gapuzari, D. Kalaitzidis, and D. Starczynowski. 2002. Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer. Cancer Lett. 181:1.
31. Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:2952.
32. Grumont, R. J., A. Strasser, and S. Gerondakis. 2002. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell. 10:1283.
33. Romieu-Mourez, R., D. W. Kim, S. M. Shin, E. G. Demicco, E. Landesman-Bollag, D. C. Seldin, R. D. Cardiff, and G. E. Sonenshein. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738.
34. Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1.
35. Borg, A., B. Baldetorp, M. Ferno, H. Olsson, and H. Sigurdsson. 1992. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer 51:687.
36. Bouchard, C., K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers. 1999. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321.
37. 1 cyclin-dependent kinases. Oncogene 21:7765.